Detalhe da pesquisa
1.
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.
Ann Hematol
; 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459156
2.
Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phase.
Haematologica
; 109(4): 1274-1278, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881883
3.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514803
4.
Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death.
Cancer
; 123(13): 2467-2471, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192602
5.
Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study.
Ann Hematol
; 96(11): 1857-1866, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28905189
6.
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Blood
; 123(26): 4027-36, 2014 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797300
7.
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy.
Haematologica
; 101(7): 839-45, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27036160
8.
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).
Blood
; 121(23): 4769-77, 2013 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23632886
9.
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
Ann Hematol
; 93(7): 1167-76, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658964
10.
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
Lancet Haematol
; 11(2): e101-e113, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38302221
11.
Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma.
Blood
; 118(24): 6292-8, 2011 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21917759
12.
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
Lancet Oncol
; 13(6): 579-88, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22503032
13.
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).
Support Care Cancer
; 19(11): 1789-95, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20953803
14.
Resonant bonding in crystalline phase-change materials.
Nat Mater
; 7(8): 653-8, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18622406
15.
CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.
Leukemia
; 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38830959
16.
Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group.
Leuk Lymphoma
; 57(3): 596-603, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26293380
17.
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
J Clin Oncol
; 28(30): 4642-8, 2010 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20805454
18.
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Blood
; 109(11): 4686-92, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17317858